Analyst
Analyst
input voltage and the resulting current that passes through an quency of ω leads to the generation of an alternating current
electrical circuit. Despite the similarity in definition and com- with a similar frequency and a phase shift. Both current and
putation between impedance and resistance values, their fun- ! !
voltage can be represented with separate vectors (VðtÞ or IðtÞ)
damental origins are different. The concept of resistance is that rotate at the same frequency. According to the data pre-
based on the utilisation of a DC signal, whereas impedance is sented in Fig. 2, it can be observed that the current and poten-
dependent upon applying an AC signal.51 The impedance tial exhibit a phase difference, which results in the possibility
could be derived by applying either voltage or current to the of vector separation by a constant phase angle (φ) as the
working electrode, and according to the transfer function: vectors undergo rotation.55 Therefore, the expression for the
Ð1 current vector of length I0 is as follows:
V ðsÞ vðtÞest dt
ZL ¼ HðSÞ ¼ ¼ Ð01 st dt
ð1Þ
IðSÞ 0 iðtÞe !
IðtÞ ¼ I0 sinðωt þ φÞ: ð4Þ
where ZL is the Laplace impedance function, s is the Laplace
frequency, V(s) and I(s) are the Laplace transforms of voltage The principle of resistance, which adheres to Ohm’s law
and current–time function.52,53 Impedance spectroscopy, in and remains unaffected by frequency, is applicable to AC cir-
contrast to conventional electrochemical techniques, rep- cuits when the vectors of current and voltage are in phase with
resents data in the frequency domain rather than time, poten- each other (as depicted in Fig. 3). The current and voltage in
tial, or current.54 Given the excitation of the electrochemical vector notation for a pure resistance (R) subjected to a sinusoi-
system through a potential sine-wave, it is possible to represent dal potential, in accordance with Ohm’s law, can be expressed
the voltage as a rotating vector (generally referred as a phasor), as follows, with a phase angle of zero:55,56
as depicted in Fig. 1, in which its length is the amplitude (V0),
and the frequency of rotation is ω as follows: !
! VðtÞ V0
IðtÞ ¼ ¼ sinðωtÞ ð5Þ
! R R
V ðtÞ ¼ V0 sinðωtÞ: ð2Þ
The angular frequency (ω) could be written as a function of ! !
conventional frequency ( f ): V ðtÞ ¼ IðtÞR: ð6Þ
Fig. 1 A sinusoidal voltage is being applied and rotating at an angular Fig. 3 The current generated when a sinusoidal potential is applied to a
frequency of ω. pure resistance.
phase shift (φ) in relation to the voltage waveform as well as ing specific information during a certain time. Under such cir-
the amplitude have an impact on the current–time function. cumstances, it is possible to measure the temporal variation of
The use of complex arguments has been suggested to facilitate resistance or capacitance. The utilisation of alternating current
mathematical procedures. In the field of complex analysis, it is signals exhibiting varying frequencies, as opposed to direct
common practise to designate the terms along the Y-axis that current waveforms, may yield more significant insights at each
pertain to capacitance behaviour as the imaginary part. This is frequency interval, encompassing the double-layer capacitance
denoted by the imaginary unit, which is represented by the of the electrochemical system being examined.57
pffiffiffiffiffiffiffi
symbol j ¼ 1. Conversely, the terms along the X-axis, which
relate to resistance behaviour, are typically regarded as the real
part.54 Accordingly, the potential in phasor notation could be 3. The beginning of impedance
expressed as follow: analysis in cell biosensing
! !
V ðtÞ ¼ jXc IðtÞ: ð8Þ Giaever and Keese37 conducted a study aimed at comprehend-
When examining the application of a sinusoidal potential ing the impacts of electromagnetic fields on cells, which led to
to a series circuit consisting of resistance and capacitance, it the development of cellular impedance biosensors.58 For the
can be observed that the overall potential is equivalent to the first time, they applied a DC potential to mammalian cells by
combined potential drop across both the resistor and the placing them between two electrodes. However, the ions ema-
capacitor. The voltage can be determined by analysing the nating from the surface of the electrodes resulted in the death
current through the impedance vector, which is represented by of the cells. The technique of impedance sensing for cellular
the equation (Z = R − iXc) as follow:55 analysis was developed by utilising a single-frequency AC
signal instead of a DC signal with a relatively high frequency
! ! ! ! !
V ¼ VR þ VC ¼ I ðR iXc Þ ¼ I Z: ð9Þ in an effort to impede the generation of ion products on the
surface. Despite this, identical impedance responses were pro-
Various plots can be used to demonstrate the impedance duced on a large working electrode regardless of whether cells
outcomes. Table 1 summarises the pertinent parameters, defi- were present or not. This observation suggested that the
nitions, and modes of illustration.57 Table 1 presents a culture solution resistance was far greater compared to that of
description of the magnitude of the impedance and the corres- the layer of cells present on the electrode, and it dominated
ponding phase angle, both of which are dependent on the fre- the overall results of the test. Since the resistance of the
medium is in line with the solid–liquid interface impedance,
the impedance response of the cells on the surface depends
extremely on the dimension of the sensing (working)
electrode.40,58 In general, the total impedance in biological
sensing employing impedance is governed by the sensing elec-
trode impedance, hence counter electrode impedance must be
lower compared to the sensing electrode.51,52,57
In the very first arrangement proposed by Giaever and
Keese, the ratio of the area of the working electrode (WE) to
the counter electrode (CE) was approximately 1 : 1500.37 The
initial setup for cell sensing in a Petri dish is illustrated in
Fig. 5. This configuration comprises a large gold electrode
Fig. 4 The current generated when a sinusoidal potential is applied to (2 cm2) functioning as a counter and four tiny golden electro-
a pure capacitance. des (3 × 10−4 cm2) serving as sensing electrodes. They used a
attributed to similar contributions from both the sensing and rc and current to be a constant value in the Z direction (verti-
counter electrodes. cal) that flows between cell–substrate interface (Fig. 7b), as
Gold has been a desirable electrode material for many years well as some simple assumptions about potential:40,79
due to its many useful properties, including being biocompati-
ble, noble, and highly conductive. However, the growing inter- d2 V 1 dV
þ ϒ 2V þ β ¼ 0 ð10Þ
est in cell imaging has been a significant motivator for transi- dr 2 r dr
tioning towards the utilisation of transparent and conductive
material electrodes.71–75 In recent years, there has been an
ρ 1 1
increasing interest among researchers in the field regarding ϒ ¼
2
þ ð11Þ
h Zn Zm
the utilisation of ITO. However, ITO exhibits lower conductivity
compared to gold and will fail to provide the same level of sen-
sitivity as gold, though it is feasible to tailor ITO to meet par- ρ Vn Vm
B¼ þ ð12Þ
ticular requirements for enhancing electrical cell sensing h Zn Zm
sensitivity.
Published on 23 November 2023. Downloaded on 12/2/2023 4:07:44 AM.
The enhancement of the electrical properties of ITO can be where the variables Vn and Vm represent the bare electrode
achieved through the use of surface treatment. According to lit- potential and the extracellular potential in the solution.
erature,76 the use of interdigitated ITO electrodes coated with Meanwhile, ρ and h denote the specific resistivity of the
IrOx can result in a reduction of interfacial impedance in com- medium in which the cells are cultured and the average cell–
parison to the use of pure ITO. This is perhaps the only study substrate distance, respectively. Additionally, Zn and Zm corres-
so far that shows how to achieve a higher sensitivity with ITO pond to the specific impedance of the solid–liquid interface
to detect electrical behaviour of cells; in this case breast cancer without cells and the specific impedance between two cellular
cells (MCF-7). membranes, respectively. The Bessel equation is a linear
second-order ordinary differential equation expressed in the
form x2y″ + xy′ + (x2 − V2)y = 0. The parameter V is commonly
4. Modelling and calculation referred to as the order of the Bessel equation. Therefore, the
Bessel function offers a linear solution to this differential
The principle of electrochemical impedance cell–substrate equation, and the following equation can be used to calculate
sensing relies on applying a relatively low AC potential the specific impedance of the electrode covered by a cell:40,80
between a sensing and counter electrode.77,78 This low voltage
2 3
is non-invasive and has been extensively shown in scientific lit- Zm
erature to be far below the level at which it might impact cellu- 1 1 6 Zn Zn þ Zm 7
¼ 64 þ 7 ð13Þ
lar processes or induce electrostimulation. It should be noted Zc Zn Zn þ Zm iϒrc I0 ðϒ rc Þ 1 1 5
þ 2Rb þ
that in impedance analysis, any voltage that can generate a 2 I1 ðϒ rc Þ Zn Zm
constant current of 1 µA is typically considered acceptable and
safe for cell research. Fig. 7a demonstrates that the current where I0 and I1 are modified Bessel functions of the first kind
pffiffiffiffiffiffiffi
path is extremely sensitive to the applied frequency.79 Giaever (order 0 and 1) with complex arguments and i ¼ 1, the
and Keese proposed the following differential equation by modified Bessel functions are expressed to expand the
assuming cells to be circular cross section with a diameter of complex variable as follows:
sffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ffi rffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ρ 1 1 1 1
ϒ rc ¼ rc þ ¼α þ ð14Þ
h Zn Zm Zn Zm
5. Application within the framework pathways in G protein-coupled receptors (GPCRs). Fig. 8b, c,
and d depict the impedance profiles pertaining to the Gi, Gq,
of the commercially available devices and Gs signalling pathways, respectively.95,96 Based on the evi-
5.1 Chemical stimulation of receptors dence, we may conclude that activating Gi-coupled receptors
Complex signalling networks are employed by cells to determine raises cellular impedance, whereas activating Gq receptors
and respond to their surrounding environmental changes.82 The results in a similar rise in impedance after a brief drop, and
processing of biological signals involves the identification of activating Gs receptors reduces cellular impedance. The
chemical stimuli through receptors on the cellular membrane.82 capacity to identify and discriminate diverse signalling path-
Upon activation, the receptor facilitates signal transduction to ways within a single assay represents a significant advance-
various cellular components by regulating specific proteins. It is ment. In the past few years, the application of cellular impe-
important to consider that a single receptor has the potential to dance biosensor has become prevalent in tackling issues
trigger numerous signalling pathways.83 Furthermore, the cell related to receptor pharmacology and the development of new
line and agonist play a role in how receptors regulate a signalling therapeutic ligands.97–103
pathway.84 This highlights the challenge of fully comprehending The combined use of electrical impedance and pharmaco-
Published on 23 November 2023. Downloaded on 12/2/2023 4:07:44 AM.
the mechanisms underlying receptor activation in living organ- logical inhibitors may shed light on cellular processes, from
isms. Assays that rely on labelling as a means of detecting recep- receptors to signalling molecules. By way of illustration,
tor activation are typically limited by their ability, as they solely Meshki et al.104 used the electrical cellular biosensor to show
monitor a single signalling pathway at any given time.85 Hence, that pre-treatment of HEK293 cells with the ROCK inhibitor
the assessment of an unfamiliar ligand’s binding to a receptor (Y27632) eliminated the blebbing and morphological changes
through conventional assays may necessitate a considerable associated with neurokinin 1 receptor (NK1R) activation,
degree of experimentation.86 leading to their interpretation shown in Fig. 9. These results
G protein activation has been widely recognised as a mecha- were in contrast to earlier studies indicating that the activation
nism that can trigger diverse signalling pathways, leading to of NK1R may result in the activation of the Gq pathway via
alterations in cellular polarity and cytoskeletal reorganisation.87,88 mechanisms including increased intracellular calcium and
The latter produces alterations in the morphology of cell that PKC stimulation. This unexpected result established for the
could be identified through the use of a cellular impedance bio- first time that the NK1R is activated through the Rho/ROCK/
sensor, suggesting the stimulation of either endogenous or MLCK pathway. In another study, Davis et al.105 highlighted
exogenous G protein-coupled receptors (GPCRs).89–92 Electrical the simplicity and speed of impedance cellular assay to study a
impedance assessments allow for continuous monitoring of mul- novel ROCK inhibitory effect.
tiple receptor activities on a single platform, such as those of tyro- Each kind of cell in an organism has its own unique set of
sine kinase receptors (TKRs), nuclear receptors and G protein- signalling pathways to interact with other cells; these pathways
coupled receptors (GPCRs).89,90,93,94
The illustration depicted in Fig. 8a demonstrates the
mechanism of signal transduction via Gq, Gi, and Gs signalling
specific adhesion of cells to bio-interfaces, as depicted in isation and intracellular calcium release in HeLa cells upon
Fig. 11. The study conducted by Atienza et al.116 showed that drug administration.
NIH3T3 cells exhibited non-specific adhesion to a surface The concept that the extracellular matrix (ECM) is com-
modified with poly-L-lysine, while they exhibited specific prised of an intricate web of multiple proteins has been widely
adhesion to a surface modified with fibronectin. The study uti- acknowledged.118 Hence, it can be inferred that different
lised an antibody targeting integrin to determine that binding sites are involved in cellular adhesion to the extra-
adhesion events were mediated by integrin receptors present cellular matrix. The study performed by Luong and col-
on the cell membrane. Additionally, the research revealed that leagues119 investigated the role of α2β1 integrin, a cellular
non-specific adhesion was facilitated by charge–charge receptor responsible for the binding of collagen and laminin.
interactions. In this study, human rhabdomyosarcoma cells were employed
Cellular and extracellular matrix (ECM) interactions are to express two variants of the α2β1 integrin receptor: the native
intricate. The diverse spatial configurations of bio-interfaces receptor (RDX2C2) and a mutant receptor lacking the α2
may impact cellular adhesion and associated intracellular domain (RDX2CO). Subsequently, an assessment was con-
signal transduction. Chockalingam et al.117 demonstrated the ducted utilising an impedance biosensor to determine the
Published on 23 November 2023. Downloaded on 12/2/2023 4:07:44 AM.
influence of interfacial architecture on the morphology of level of adhesion on micro-electrodes coated with collagen,
cells. A monolayer coating of organo phosphonate was utilised laminin, and fibronectin. The study demonstrated that cells
as a base layer, followed by the sequential construction of bio- that expressed the α2β1 integrin receptor (RDX2C2) exhibited a
interfaces through a stepwise fabrication process. significant increase in adhesion to surfaces that were modified
Subsequently, the ratio of molecules that were attached to the with collagen and laminin. In contrast, the cells that expressed
self-assembled monolayers (SAMs) was regulated prior to the a mutant α2β1 integrin receptor (RDX2CO) demonstrated only
introduction of GRGDC, a cell-adhesive ligand, as the third a slight rise in their adherence to these particular surfaces.
step in the process of cell–molecule coupling. The study Furthermore, it was observed that cells that expressed the α2β1
revealed that the time taken by cells to spread on a precisely integrin receptor (RDX2C2) exhibited a slight elevation in their
defined surface is exquisitely sensitive to the adhesive ligand surface adhesion ability to the modified surface with fibronec-
density on the surface. The impact of surface chemistry on tin. Conversely, cells that expressed the mutant α2β1 integrin
signal processing within cells was revealed in a more recent receptor (RDX2CO) did not demonstrate any adhesion to the
study conducted by the same group.75 The utilisation of a cel- fibronectin-modified surface.
lular impedance biosensor and fluorescence microscopy in a The utilisation of cellular impedance biosensors has the
single device demonstrated that the modification of RGD potential to elucidate a more comprehensive understanding of
spacing on the surface has an impact on cytoskeletal reorgan- cellular behaviour beyond the mere examination of cellular–
ECM interactions. Sawhney et al.,120 investigated the motility
and locomotion of HCT116 cells on surfaces modified with
bovine serum albumin (BSA) and collagen type IV. A notable
characteristic of the resistance profile over time for cells on a
surface modified with collagen type IV was the significant fluc-
tuation of resistance, which suggests the occurrence of micro-
movements of cells on the electrode. In contrast, electrodes
that had undergone surface modification with BSA did not
exhibit any fluctuations, suggesting the absence of micro-
movement. The absence of cell attachment was suggested by
the apparent lack of motility on the BSA modified electrode, as
it is commonly believed that cell motility and attachment to
the surface are biologically linked.
The human immune system is a complex network that
defends the body from disease by deploying specialised
immune cells or proteins to the site of infection. As an
example, the process of leukocyte circulation on endothelial
cells has the potential to trigger the activation of leukocyte
integrins, subsequently leading to their adherence to the endo-
thelial cells. This facilitates the stimulation of actin cytoskele-
Fig. 11 (a) Real-time impedance assessment of NIH3T3 cell adhesion ton reorganisation in endothelial cells, which promotes the
and spreading was conducted using microelectrodes modified with transmigration of leukocytes into the tissue.121 Cellular impe-
poly-L-lysine and fibronectin. (b) Fluorescence images of NIH3T3 cells
dance biosensors are extremely sensitive at detecting altera-
on glass slides modified with poly-L-lysine and fibronectin. The cells
were subjected to staining using rhodamine-phalloidin. The displayed
tions in intercellular junctions and cell–matrix adhesions,
content reproduced from ref. 116. Copyright 2005 Elsevier; permission making them a suitable tool for monitoring the function and
obtained through Copyright Clearance Center, Inc. dysfunction of endothelial barriers. The cellular endothelial
barrier function is a crucial component in facilitating adaptive function of lung cells. The paper suggests activation of the LPA
immune responses through the process of mobilising immune receptor resulted in an increase in transepithelial resistance,
cells to an injured area. thereby indicating an improvement in barrier function.
According to Wegener et al.122 research, the cAMP-depen- Applying impedance analysis provided evidence that the
dent cellular signalling pathway regulates the defensive func- mechanism of action was through E-cadherin clustering at
tions of choroid plexus epithelial cells, as demonstrated by cell–cell interface. In contrast, the signalling pathway regard-
impedance data. The data analysis revealed that choroid ing TLRs induced epithelial barrier disruption. The transloca-
plexus epithelial cells showed an increased impedance when tion of E-cadherin from the plasma membrane to the cyto-
cAMP was boosted, which suggests a decline in the per- plasm, which was caused by the activation of TLRs, was found
meability of the epithelial barrier function. Similarly, Qiao to be reversed by the activation of LPA, as depicted in Fig. 12.
et al.,123 conducted a study to explore the protective mecha- The intricate arrangement of endothelial cells, which
nism against endothelial barrier dysfunction. The study inves- includes the blood–brain barrier (BBB), are in close proximity
tigated the protective function of human microvascular endo- to one another and form tight junctions between cells in all
thelial cells (HMEC) and pre-treated HMEC (with cAMP-elevat- blood vessels in the brain. The BBB operates as a selective bar-
Published on 23 November 2023. Downloaded on 12/2/2023 4:07:44 AM.
ing drugs) to thrombin using a cellular impedance biosensor. ricade that limits the transit of potentially harmful substances
The impedance findings indicate that the reduction in resis- from the bloodstream to the central nervous system, thereby
tance linked to the barrier dysfunction was partially alleviated safeguarding the brain. To date, the most reliable approach for
following the administration of cAMP-elevating medications to analysing the permeability of the blood–brain barrier (BBB)
HMEC. Given that RhoA is involved in the modulation of involves the quantification of transepithelial electrical resis-
HMEC barrier breakdown, it was assumed that the activation tance (TER), which quantifies the restriction of the current
of RhoA could be suppressed by the signalling cascade invol- flow through a monolayer of cells.125 A remarkable character-
ving cAMP-dependent protein kinase (PKA). Therefore, it is istic of the blood–brain barrier is its exceptional capability to
hypothesised that the PKA signalling pathway serves as a resist electrical signals, which is attributed to the presence of
mechanism to mitigate dysfunction of the vascular endothelial tight junctions within the cellular monolayer.126 The impact of
barrier in reaction to diverse inflammatory mediators. cocaine on HIV-1 invasion through the blood–brain barrier
A further assessment of electrical resistance in human was explored by Fiala et al.,127 through the utilisation of cellu-
bronchial epithelial cells (HBEpCs) has revealed the molecular lar electrical impedance. It was shown that the impact of
mechanisms and crosstalk between two different signalling cocaine on brain microvascular endothelial cells (BMECs) was
pathways, as depicted in Fig. 12. He et al.,124 investigated the to cause a disruption of intracellular tight junctions and as a
contribution of the crosstalk between lysophosphatidic acid consequence invasion by HIV-1 was elevated.
receptor (LPA-Rs) and toll-like receptor (TLRs) to the defensive Kataoka et al.,128 conducted a study to examine the inter-
action between arterial endothelial cells and monocytes using
a cellular impedance biosensor and atomic force microscopy.
It was found that the electrical resistance of HUVEC (endo-
thelial cells found in human umbilical veins) exhibited an
instant drop upon being exposed to THP-1, a human monocy-
tic cell line. This behaviour linked to the reduced adhesiveness
and increased deformability of endothelial cells. In a similar
study, Ge et al.129 demonstrated the influence of lipopolysac-
charide (LPS) on the adhesion of leukocytes (U937) to the cells
derived from HUVECs. They showed that the pre-treatment of
HUVECs with LPS caused a decline in adhesion between endo-
thelial cells and substrate that was dependent upon the LPS
dosage. Cellular communication may occur through the
secretion of substances that bind to the receptor of a specific
cell upon activation. Treeratanapiboon et al.130 conducted a
study wherein they triggered human peripheral blood mono-
nuclear cells (PBMC) using membrane-associated malarin
Fig. 12 A schematic illustration of the mechanism that protects the epi-
antigen. This research investigated the effects of activated
thelial barrier disruption induced by lipopolysaccharide (LPS) ligand. The blood cells on the barrier function of porcine brain capillary
LPS activates toll-like receptor 4 (TLRs) regulating mislocalisation of endothelial cells (PBCEC) using a cellular impedance bio-
E-cadherin from cell membrane to cytoplasm. In contrast, the post- sensor. The release of tumour necrosis factor-alpha from
treatment of lysophosphatidic acid (LPA) receptor activates focal
infected blood cells caused increased permeability of the
adhesion kinase (FAK), downstream of protein kinase C (PKC) δ and γ,
that accumulate E (epithelial)-cadherin from the cytoplasm to cell–cell
blood–brain barrier due to damaged tight junctions.
junction and recover the barrier disruption induced by LPS. The dis- Mast cells are a type of primary immune cell that exhibit
played content reproduced from ref. 124. Copyright 2009 Elsevier. rapid responsiveness to allergic stimuli by triggering their
high-affinity immunoglobulin E (IgE) receptor, commonly D143V_CXCR2 increased at the same rate, suggesting cell pro-
referred to as FcεRI.131 The immune system generates liferation. The WT-CXCR2 exhibited a plateau phase sub-
immunoglobulin E (IgE) as the predominant antibody to safe- sequent to 3000 minutes (50 hours), whereas the
guard the body against allergic reactions. The study conducted D143V_CXCR2 continued to grow throughout the entire dur-
by Abassi et al.132 involved a comparison of the IgE-mediated ation of the experiment, spanning 5000 minutes, without any
signal in RBL-2H3 mast cells using a cellular impedance bio- indication of deceleration. Due to the collapse of contact inhi-
sensor and β-hexosaminidase assay. They identified a corre- bition between the cells, there was unregulated cellular replica-
lation between the electrical signal obtained from impedance tion on top of one another, which led to the development of
and the morphological dynamics, as well as the mediator tumours and a constantly rising impedance profile.
released obtained from the β-hexosaminidase assay. The continuous monitoring of cellular adhesion and move-
ment is critical in understanding cellular processes such as
5.3 Cancer research investigation cellular mitosis, tumour spreading, and cell locomotion in cell
biology.139 Cellular motility is a characteristic associated with
Biosensors that use impedance measurements can differen-
the metastatic potential of malignant cells. Using the impe-
tiate between various human and animal cancer cells by ana-
Published on 23 November 2023. Downloaded on 12/2/2023 4:07:44 AM.
Öz et al.145 employed cell-based impedance biosensors to into a host cell may result in alterations to the cellular struc-
analyse changes in the bioelectrical characteristics of NT2 cells ture. Cytopathic effects caused by viral infections, for example,
after they were treated with nucleoside analogues such as are characterised by cellular swelling, clumping, partial disin-
1β-arabinofuranosylcytosine and 29-deoxy-5-azacytidine. tegration, and, in the most extreme cases, full cellular annihil-
Unlike other approaches, such as phase contrast microscopy ation.148 Fig. 16 depicts how impedance fluctuates over time,
or gene expression profiling using PCR, they were successful in with cell attachment and spreading causing an increase in
identifying early differentiation stages during the first day of impedance and infections causing a drop in impedance.
therapy through recording alterations to impedance profiles. In addition to being able to assess the deterioration of cell
This implies that impedance sensing of the cells exhibits high monolayers in relation to pathogen loading concentration, an
sensitivity and resilience as a means of evaluating the impact added benefit of this approach is its potential to offer real-
of differentiation-inducing drugs on cellular systems. time insights into the virulence capabilities of various patho-
Consequently, they offer significant contributions to the gen strains.149 The study conducted by Fang et al.150 employed
understanding of drug mechanisms and cellular differen- mathematical modelling to analyse dynamic cellular changes
tiation processes. The electrochemical impedance biosensor obtained from electrical impedance. The findings suggest that
Published on 23 November 2023. Downloaded on 12/2/2023 4:07:44 AM.
could be employed to characterize the inhibition properties of the replication rate of West Nile Virus in Vero cells is approxi-
some chemicals to anti-cancer drugs. Fig. 15a shows the apop- mately three times faster than that of St. Louis encephalitis
tosis induced by treating squamous cell carcinoma cancer cell virus. An additional example of this trend is apparent in the
line (CAL 27) with different concentration of cisplatin as anti- research conducted by Nahid et al.149 wherein they investi-
cancer drug. The inhibitory effect of nicotine on anti-cancer gated the impact of four primary clinical bacterial strains on
effect of cisplatin can be seen in Fig. 15b. The results show the kinetic apoptosis of lung epithelial cells (A549). The
that any amount of nicotine reduces the effect of cisplatin on electrochemical findings indicate a restricted alteration in re-
cancer cells, with the cisplatin rendered ineffective at a nic- sistance upon Pseudomonas aeruginosa infection within a
otine concentration of 1 µM or higher.146 12-hour timeframe. However, infections with Enterococcus,
Staphylococcus aureus, and ESBL Escherichia coli all experienced
5.4 Microbiological investigation
The use of impedance-based cellular biosensors presents a
rapid and convenient approach for tracking the kinetic
response of biological cells to invading pathogens in the clini-
cal microbiology laboratory.147 The invasion of a pathogen
a significant decline over the course of the first 5 hours, albeit advanced our grasp of cell physiology because they are so easy
with distinct patterns. to prepare in high throughput, these models have some limit-
The utilisation of impedance analysis within microbiology ations, including an inability to adequately replicate drug
laboratories for the assessment of cell/pathogen interaction penetration into tissues and the complex structure of real
has expanded beyond the determination of pathogen virulence tissue.164 The capability of an AC electrical signal to pass
capacity. McCoy et al.151 conducted a study utilising a cellular across a tissue (without interfering with or harming) makes
impedance biosensor to measure the response of MDCK cells the impedance method an attractive experimental technique
to influenza A virus. A notable finding from the research con- for screening cells in three dimensions (3D).165 Fig. 17 shows
ducted was that the administration of ammonium chloride, a the underlying concept of cellular impedance in both two- and
widely recognised viral inhibitor, resulted in an alteration in three-dimensional models of cell culture.165 In a 2D environ-
the electrical findings, suggesting that the entry of the virus ment, adherent cells are seeded directly on the surface of elec-
into the cells was impeded. Since then, cellular impedance trodes. When analysing the morphological behaviour of adher-
biosensors have been extensively employed in research endea- ent cells on microelectrodes in a 2D model, it is necessary to
vours to probe prospective innovative antiviral drugs.152–157 account for the flow of electrical signal through the resistance
Published on 23 November 2023. Downloaded on 12/2/2023 4:07:44 AM.
The significance of the electrical cellular biosensor in asses- of bulk medium (Rs) and the dielectric barrier of cells
sing the effectiveness of neutralising antibodies during the (Fig. 17a). By reducing the influence of solution resistance, the
2009 Influenza A (H1N1) virus pandemic was demonstrated by electrical signal provides sensitive insights about the intercel-
Tian et al.158 More recently, Charretier et al.159 proposed the lular junctions and adherence of cells to the microelectrode.
use of impedance-based cellular assays as a potential alterna- In contrast, in a 3D cell culture surroundings, cells attach to
tive to the conventional TCID50 assay for measuring viral the structural support or to other cells rather than coming into
infectious titers in vaccine development. full association with microelectrodes (Fig. 17c). When a 3D cell
Cellular impedance biosensors can potentially elucidate the culture environment is placed between electrodes, the culture
underlying mechanism of viral infections. Viruses employ media and electrodes are in direct contact with one another.
receptor binding as a mechanism to access the cellular As a result, there is always a route for current flow between
machinery of the host.160 For instance, the expression of the electrodes that escapes the cells (shunt current) which affects
AXL receptor has been widely acknowledged to facilitate the the sensitivity of measurements. By altering electrode designs,
entry of the ZIKV virus into cells.161 In order to enhance com- it is feasible to enhance the contact between cells and electro-
prehension of the mechanisms underlying Zika virus invasion des and so lower the shunt current.
of human cells, Ismail A. A. et al.162 employed cellular impe- As an example, Pan et al.166 developed a three-dimensional
dance biosensor to scrutinise the impact of viral infection on cell-based impedance biosensor (known as 3D-ECMIS) as an
brain microvascular endothelial cells. The study involved the ongoing monitoring platform for analysis of cell proliferation
use of mathematical modelling to examine impedance data. and drug efficacy testing. Two gold sensor plates were arranged
The parameters considered in the analysis included the vertically in each sensor channel of the 3D impedance bio-
barrier function of cell–cell interaction (Rb), the adhesion sensor chip, which included 8 individual culture wells on an
value of cell–surface interaction (α), and the possibility for optical base (Fig. 18). A Matrigel scaffold (Matrigel is an extra-
pathogenic agents to affect the membrane capacitance of a cellular matrix mimic) was utilized to encapsulate the human
cell. According to the ECIS results, the virus expedited the hepatoma cells (HepG2) before they were cultured in the bio-
process of vascular leakage in the brain, thereby disrupting
the permeability properties of microvascular endothelial cells
in the brain.
activities that are taking place inside of the cells.89 Despite the
many benefits of multitasking on a single platform, impe-
dance signals, due to their holistic and comprehensive nature,
are rarely able to identify particular molecular processes occur-
ring inside the cells.179 Additionally, certain significant intra-
cellular biomolecular processes have an indirect effect, or have
no influence at all, on the total impedance reading.96 An
example of this kind of concerns is the use of an electrical cell-
based biosensor as a readout to describe G protein coupled
receptor (GPCR) stimulation. The capability of cellular impe-
dance biosensors to differentiate between the Gi, Gq, and Gs
signalling pathways has been the subject of extensive
Fig. 18 (a) An impedance biosensor design for three dimensions cell research.89–91,180 Recent findings, however, have shown that
culturing. (b) Illustration of a three-dimensional impedance biosensor the cell line has a significant effect on the electrical response
Published on 23 November 2023. Downloaded on 12/2/2023 4:07:44 AM.
and ECIS techniques at the same time. The displayed content repro-
while time-dependent impedance findings in both profiles duced from ref. 183. Copyright 2013 Elsevier; permission obtained
indicate different stages of cell attachment on the surface, the through Copyright Clearance Center, Inc.
impedance measurements are not indicative of the surface cov-
erage. Accordingly, cells tightly adhering to a small fraction of
the electrode surface lacking intracellular attachment could
reveal the same profile as a confluent cell layer with loose beyond the detection limit of the SPR approach. This study
attachment to the surface. showed the ECIS-SPR dual sensor better characterised how
Hyphenated cell-based impedance assays have attracted cytoskeleton active medicines affect various subcellular com-
growing attention in recent years as a complement to other partments and cellular functions.
relevant cell research methods. Such hybrid techniques have Because microfluidic devices are increasingly being utilised
been used in the field, and some examples are impedance- in cell studies, the combination of microfluidics with impe-
quartz crystal microbalance (QCM),182 impedance-surface dance-based measurements of cells is becoming increasingly
plasmon resonance spectroscopy (SPR),183 impedance-light- popular.185–189 Impedance implementation in microfluidic
addressable potentiometric sensor (LAPS)184 and impedance systems may be useful from a number of perspectives.
flow cytometry.185 More precise data may be generated with Integrating impedance microelectrodes into microfluidic
the help of cell-based hybrid biosensors. Impedance and devices enables detailed analysis of single cells rather than cell
surface plasmon resonance (SPR) cell-based assays are two populations opening the door to more fundamental biological
such approaches that, when used independently, show the research.189 Additionally, impedance flow cytometry does not
advantages and disadvantages of each method for answering need adherent cells. The fact that a majority of cell lines
certain questions. exhibit a lack of adherence to gold or glass electrodes presents
The optical SPR readout only identifies changes near to the a technical hurdle in classical cell–substrate impedance
substrate surface (200 nm). Tight junction which allows cells measurement. Controlling cell adhesion prior to doing the
to communicate with other cells is an example of a morpho- experiment using a traditional impedance technique is there-
logical change that lies above the evanescent wave of SPR. The fore crucial, and the fabrication of bio-interfaces or an artifi-
electrical impedance readout, however, gives information cial extracellular matrix may be necessary. These bio-interface
about the entirety of the cell body, encompassing interactions materials, however, could not precisely resemble the extracellu-
between cells and between cells and substrates. Therefore, lar matrix, which might change the shape and adhesion
surface plasmon resonance (SPR) integration on an impedance characteristics of cells.58
cell-based platform has the potential to enhance comprehen- Ayliffe and colleagues190 were the pioneers in developing a
sion of morphological alternations occurring at the subcellular microfluidic system that incorporated microelectrodes for the
level. Using the developed dual biosensor, Michaelis et al.183 purpose of detecting cellular bioelectrical activity at the single
employed confluent MDCK II cells to investigate the impact of level. Single cell electrical characteristics may serve as biologi-
cytochalasin D (CD). To evaluate the cellular response to cyto- cal biomarkers to categorise different type of cells including
skeletal rearrangement, 5 µM CD was introduced to MDCK cell blood cells, tumour and stem cells.191 Microfluidic impedance
monolayer while SPR and impedance experiments were con- cytometry outcome is based on the biophysical aspects of cells
ducted simultaneously. SPR and impedance time courses like their size, shape and the dielectric properties of their
show that the decrease in impedance exhibits a more rapid membranes. Numerous studies have shown the capacity of
rate of change in comparison to the decline in reflectivity impedance cytometry systems to distinguish cancer cells utilis-
(Fig. 20). The SPR readings predominantly disclose the cytos- ing various designs.192–197 One example is a microfluidic impe-
keleton transformation near the lower cell body, but impe- dimetric device designed to identify leukaemia cells. It was
dance measurements (at low frequencies) are indeed very sen- demonstrated that normal red blood cells (RBCs) and cancer-
sitive to alternations in the junctions of cell–cell, which is ous ones could be effectively differentiated.198 The signal to
noise ratio (SNR) was examined by altering the excitation demonstrating strong metastatic potential. The findings of the
voltage and ionic concentration in solution. The channel geo- impedance recording showed that the phase component of
metry was also optimised to enhance the sensitivity of the impedance may be utilised to discriminate between the meta-
output signal. Human red blood cells (RBCs) and leukaemia static condition of HNC cells at the level of single-cell.
cells (LCs) were separately suspended in a 2.5 S m−1 conduct- In another study, Nguyen et al.201 developed an impedance-
ing buffer solution. By pumping suspensions to the channel at integrated microfluidic system utilising the Boyden chamber
a pressure difference of 30 mbar and a release rate of five concept, which is comprised of three primary components: a
microliters per hour, a flow of 2000 cells per min was attained. microfluidic channel, cell capture spots, and an impedance
When a voltage of 3 V was applied to the electrode and a microelectrode. The device enabled to rapidly and selectively
1.5 MHz electric pulse was generated, both cell types produced identify migratory characteristics of single cancer cells. More
distinct signal waveforms with a focus on the single events recently, a microfluidic device was developed202 allowing sim-
(Fig. 21). ultaneous investigation of static and dynamic cells by combin-
A single cell may be precisely contained at a specific ing electric impedance flow cytometry and EIS on the same
location of microfluidic structural using innovative designs, platform (Fig. 22). The tool has been shown to be effective at
Published on 23 November 2023. Downloaded on 12/2/2023 4:07:44 AM.
opening novel possibilities for combinations with impedance both letting dynamic cells through for impedance flow cytome-
microelectrodes. According to the published literature, there try assessments and capturing them for EIS readings. The
are two categories of impedance biosensors that use microflui- entire impedance spectrum may be recorded by EIS, which
dic technology.199 Microfluidic impedance cytometry may be provides a broad range of data about the unique properties of
used to analyse either dynamic or static cells (that have been the cells. HepG2, HeLa and A549 cancer cell populations were
trapped in a microcavity structure). As an example of a station- separately assessed using the microfluidic device. Impedance
ary cell examined through a spectrum of impedance utilising a flow cytometry readout revealed that the magnitude degree of
microfluidic device, Cho et al.,200 combined flow channel for impedance was very different between malignant cells. While
cells with cell trapping sites and opposing microelectrode the whole impedance spectrum of a single cell, which was
arrays for impedance measurement. By exerting suction via the recorded by EIS, was employed to obtain specific biophysical
microchannel designed specifically for cell trapping, a single information about each cell type, including the dimension of
cell was pulled into the microfluidic cell capture site as it the cells, specific cellular capacitance, and intracellular resis-
moved down the cell flow channel. Upon capturing an individ- tivity. This work showed that integrating EIS to impedance
ual cell within the designated electrical analysis spot, the flow cytometry presents a novel method to expand knowledge
syringe pump was promptly turned off. Following this, impe- regarding electrical characteristics of single cells.
dance analysis was performed on the captured cells using a More than 50 years of research have focused on the corre-
voltage of 500 mV, spanning a frequency spectrum of 40 Hz to lation of cell deformability and chronic illnesses.203
10 MHz. The study acquired impedance spectrum data from Consequently, the deformability of cells may serve as a funda-
two different head and neck carcinoma (HNC) cell lines, mental biomarker for diagnosing diseases.203 The biomechani-
characterised by varying degrees of metastatic potential, with cal characteristics of a cell can be measured by deforming the
one exhibiting limited metastatic potential and the other cell. One effective way to induce mechanical stimuli is using
constriction channels, which are only slightly smaller in dia-
meter than the measured cell sizes.204 When cells are pushed
ent efforts and creative ideas, impedance monitoring of cells is 14 P. Jin, Z. Ren, F. Ye and W. Ying, Anal. Biochem., 2014,
prepared to significantly advance biological study and health 450, 27–29.
care applications. 15 T. Söllradl, F. A. Banville, U. Fröhlich, M. Canva,
P. G. Charette and M. Grandbois, Biosens. Bioelectron.,
2018, 100, 429–436.
Author contributions 16 J. S. Daniels and N. Pourmand, Electroanalysis, 2007, 19,
1239–1257.
Seyedyousef Arman: conceptualization, writing – original draft, 17 R. Halai, D. E. Croker, J. Y. Suen, D. P. Fairlie and
writing – review & editing. J. Justin Gooding and Richard M. A. Cooper, Biosensors, 2012, 2, 273–290.
D. Tilley: supervision, conceptualization, funding acquisition, 18 B. Liedberg, C. Nylander and I. Lundström, Biosens.
writing – original draft, writing – review & editing. Bioelectron., 1995, 10, i–ix.
19 M. Hide, T. Tsutsui, H. Sato, T. Nishimura, K. Morimoto,
S. Yamamoto and K. Yoshizato, Anal. Biochem., 2002, 302,
Conflicts of interest 28–37.
Published on 23 November 2023. Downloaded on 12/2/2023 4:07:44 AM.
39 K. Benson, S. Cramer and H.-J. Galla, Fluids Barriers CNS, 64 A. R. A. Rahman, C.-M. Lo and S. Bhansali, Sens.
2013, 10, 1–11. Actuators, B, 2006, 118, 115–120.
40 I. Giaever and C. R. Keese, Proc. Natl. Acad. Sci. U. S. A., 65 J. Wegener, M. Sieber and H.-J. Galla, J. Biochem. Biophys.
1991, 88, 7896–7900. Methods, 1996, 32, 151–170.
41 C. M. Dowling, C. Herranz Ors and P. A. Kiely, Biosci. Rep., 66 J. A. Stolwijk, K. Matrougui, C. W. Renken and M. Trebak,
2014, 34(4), e00126. Pfluegers Arch., 2015, 467, 2193–2218.
42 K. Le Gal, M. X. Ibrahim, C. Wiel, V. I. Sayin, M. K. Akula, 67 J. Wegener, S. Zink, P. Rösen and H.-J. Galla, Pfluegers
C. Karlsson, M. G. Dalin, L. M. Akyürek, P. Lindahl and Arch., 1999, 437, 925–934.
J. Nilsson, Sci. Transl. Med., 2015, 7, 308re308. 68 R. Ehret, W. Baumann, M. Brischwein, A. Schwinde,
43 Y. Huang, D. J. Burns, B. E. Rich, I. A. MacNeil, K. Stegbauer and B. Wolf, Biosens. Bioelectron., 1997, 12,
A. Dandapat, S. M. Soltani, S. Myhre, B. F. Sullivan, 29–41.
C. A. Lange and L. T. Furcht, BMC Cancer, 2017, 17, 1–18. 69 J. Hong, K. Kandasamy, M. Marimuthu, C. S. Choi and
44 C. Tiruppathi, A. B. Malik, P. J. Del Vecchio, C. R. Keese S. Kim, Analyst, 2011, 136, 237–245.
and I. Giaever, Proc. Natl. Acad. Sci. U. S. A., 1992, 89, 70 M. Sperber, C. Hupf, M.-M. Lemberger, B. Goricnik,
Published on 23 November 2023. Downloaded on 12/2/2023 4:07:44 AM.
88 S. Etienne-Manneville and A. Hall, Nature, 2002, 420, 629– 112 H. Perinpanayagam, R. Zaharias, C. Stanford, R. Brand,
635. J. Keller and G. Schneider, J. Orthop. Res., 2001, 19, 993–
89 N. Yu, J. M. Atienza, J. Bernard, S. Blanc, J. Zhu, X. Wang, 1000.
X. Xu and Y. A. Abassi, Anal. Chem., 2006, 78, 35–43. 113 S. Hirohashi and Y. Kanai, Cancer Sci., 2003, 94, 575–
90 G. Leung, H. R. Tang, R. McGuinness, E. Verdonk, 581.
J. M. Michelotti and V. F. Liu, JALA, 2005, 10, 258–269. 114 A. A. Khalili and M. R. Ahmad, Int. J. Mol. Sci., 2015, 16,
91 E. Verdonk, K. Johnson, R. McGuinness, G. Leung, 18149–18184.
Y.-W. Chen, H. R. Tang, J. M. Michelotti and V. F. Liu, 115 T. Okegawa, R.-C. Pong, Y. Li and J.-T. Hsieh, Acta
Assay Drug Dev. Technol., 2006, 4, 609–619. Biochim. Pol., 2004, 51, 445–457.
92 M. F. Peters and C. W. Scott, J. Biomol. Screening, 2009, 14, 116 J. M. Atienza, J. Zhu, X. Wang, X. Xu and Y. Abassi,
246–255. J. Biomol. Screening, 2005, 10, 795–805.
93 A. Vlachodimou, A. P. IJzerman and L. H. Heitman, Sci. 117 M. Chockalingam, A. Magenau, S. G. Parker, M. Parviz,
Rep., 2019, 9, 1–10. S. Vivekchand, K. Gaus and J. J. Gooding, Langmuir, 2014,
94 K. Miyano, K. Ohbuchi, Y. Sudo, K. Minami, T. Yokoyama, 30, 8509–8515.
Published on 23 November 2023. Downloaded on 12/2/2023 4:07:44 AM.
M. Yamamoto, M. Uzu, M. Nonaka, S. Shiraishi and 118 K. A. Piez and A. Reddi, Extracellular matrix biochemistry,
H. Murata, J. Pharmacol. Sci., 2020, 143, 320–324. Elsevier, 1984.
95 M. F. Peters, F. Vaillancourt, M. Heroux, M. Valiquette and 119 J. H. Luong, C. Xiao, B. Lachance, Š. M. Leabu, X. Li,
C. W. Scott, Assay Drug Dev. Technol., 2010, 8, 219–227. S. Uniyal and B. M. Chan, Anal. Chim. Acta, 2004, 501,
96 J. Doijen, T. Van Loy, B. Landuyt, W. Luyten, D. Schols 61–69.
and L. Schoofs, Biosens. Bioelectron., 2019, 137, 33–44. 120 R. S. Sawhney, G.-H. K. Zhou, L. E. Humphrey, P. Ghosh,
97 X. Yang, M. A. Dilweg, D. Osemwengie, L. Burggraaff, J. I. Kreisberg and M. G. Brattain, J. Biol. Chem., 2002,
D. van der Es, L. H. Heitman and A. P. IJzerman, Biochem. 277, 75–86.
Pharmacol., 2020, 180, 114144. 121 W. A. Muller, Lab. Invest., 2002, 82, 521–534.
98 E. W. Verweij, B. Al Araaj, W. R. Prabhata, R. Prihandoko, 122 J. Wegener, A. Hakvoort and H.-J. Galla, Brain Res., 2000,
S. Nijmeijer, A. B. Tobin, R. Leurs and H. F. Vischer, ACS 853, 115–124.
Pharmacol. Transl. Sci., 2020, 3, 321–333. 123 J. Qiao, F. Huang and H. Lum, Am. J. Physiol.: Lung Cell.
99 M. L. Doornbos, I. Van der Linden, L. Vereyken, Mol. Physiol., 2003, 284, L972–L980.
G. Tresadern, A. P. IJzerman, H. Lavreysen and 124 D. He, Y. Su, P. V. Usatyuk, E. W. Spannhake, P. Kogut,
L. H. Heitman, Biochem. Pharmacol., 2018, 152, 201–210. J. Solway, V. Natarajan and Y. Zhao, J. Biol. Chem., 2009,
100 M. L. Doornbos, J. M. Cid, J. Haubrich, A. Nunes, 284, 24123–24132.
J. W. van de Sande, S. C. Vermond, T. Mulder-Krieger, 125 B. Srinivasan, A. R. Kolli, M. B. Esch, H. E. Abaci,
A. A. Trabanco, A. Ahnaou and W. H. Drinkenburg, J. Med. M. L. Shuler and J. J. Hickman, J. Lab. Autom., 2015, 20,
Chem., 2017, 60, 6704–6720. 107–126.
101 J. Doijen, T. Van Loy, W. De Haes, B. Landuyt, W. Luyten, 126 Y. Fang, Int. J. Electrochem., 2011, 2011, 460850.
L. Schoofs and D. Schols, PLoS One, 2017, 12, e0185354. 127 M. Fiala, A. J. Eshleman, J. Cashman, J. Lin,
102 K. Webling, J. Runesson, A. Lang, I. Saar, B. Kofler and A. S. Lossinsky, V. Suarez, W. Yang, J. Zhang, W. Popik
Ü. Langel, Neuropeptides, 2016, 60, 75–82. and E. Singer, J. NeuroVirol., 2005, 11, 281–291.
103 D. Thirkettle-Watts, Biochem. Biophys. Rep., 2016, 6, 32–38. 128 N. Kataoka, K. Iwaki, K. Hashimoto, S. Mochizuki,
104 J. Meshki, S. D. Douglas, J.-P. Lai, L. Schwartz, L. E. Kilpatrick Y. Ogasawara, M. Sato, K. Tsujioka and F. Kajiya, Proc.
and F. Tuluc, J. Biol. Chem., 2009, 284, 9280–9289. Natl. Acad. Sci. U. S. A., 2002, 99, 15638–15643.
105 R. L. Davis, M. Kahraman, T. J. Prins, Y. Beaver, 129 Y. Ge, T. Deng and X. Zheng, Acta Biochim. Biophys. Sin.,
T. G. Cook, J. Cramp, C. S. Cayanan, E. M. Gardiner, 2009, 41, 256–262.
M. A. McLaughlin and A. F. Clark, Bioorg. Med. Chem. 130 L. Treeratanapiboon, K. Psathaki, J. Wegener,
Lett., 2010, 20, 3361–3366. S. Looareesuwan, H.-J. Galla and R. Udomsangpetch,
106 R. C. Hardie and K. Franze, Science, 2012, 338, 260–263. Biochem. Biophys. Res. Commun., 2005, 335, 810–818.
107 R. M. Fischer, B. M. Fontinha, S. Kirchmaier, J. Steger, 131 H. J. Gould, B. J. Sutton, A. J. Beavil, R. L. Beavil,
S. Bloch, D. Inoue, S. Panda, S. Rumpel and K. Tessmar- N. McCloskey, H. A. Coker, D. Fear and L. Smurthwaite,
Raible, PLos Biol., 2013, 11, e1001585. Annu. Rev. Immunol., 2003, 21, 579–628.
108 J. T. Davis, O. Okunola and R. Quesada, Chem. Soc. Rev., 132 Y. A. Abassi, J. A. Jackson, J. Zhu, J. Oconnell, X. Wang
2010, 39, 3843–3862. and X. Xu, J. Immunol. Methods, 2004, 292, 195–205.
109 A. Vlachodimou, A. P. IJzerman and L. H. Heitman, Sci. 133 T. Anh-Nguyen, B. Tiberius, U. Pliquett and G. A. Urban,
Rep., 2019, 9, 13802. Sens. Actuators, A, 2016, 241, 231–237.
110 C. C. Wang, Y. Hsu, F. Su, S. Lu and T.-M. Lee, J. Biomed. 134 F. E. Giana, F. J. Bonetto and M. Bellotti, Meas. Sci.
Mater. Res., Part A, 2009, 88, 370–383. Technol., 2019, 31, 025702.
111 K. A. Marx, T. Zhou, A. Montrone, D. McIntosh and 135 F. E. Giana, F. J. Bonetto and M. I. Bellotti, Phys. Rev. E,
S. J. Braunhut, Anal. Biochem., 2007, 361, 77–92. 2018, 97, 032410.
A. J. Sanders, Cancer Metastasis Rev., 2015, 34, 753–764. 168 S. H. Jeong, D. W. Lee, S. Kim, J. Kim and B. Ku, Biosens.
143 W. G. Jiang, T. A. Martin, J. M. Lewis-Russell, A. Douglas- Bioelectron., 2012, 35, 128–133.
Jones, L. Ye and R. E. Mansel, Mol. Cancer, 2008, 7, 1–10. 169 H. Wu, Y. Yang, P. O. Bagnaninchi and J. Jia, Analyst,
144 H. Yin, F. L. Wang, A. L. Wang, J. Cheng and Y. Zhou, 2018, 143, 4189–4198.
Anal. Lett., 2007, 40, 85–94. 170 S.-M. Lee, N. Han, R. Lee, I.-H. Choi, Y.-B. Park, J.-S. Shin
145 S. Öz, C. Maercker and A. Breiling, PLoS One, 2013, 8, and K.-H. Yoo, Biosens. Bioelectron., 2016, 77, 56–61.
e59895. 171 K. F. Lei, Z.-M. Wu and C.-H. Huang, Biosens. Bioelectron.,
146 L. R. Arias, C. A. Perry and L. Yang, Biosens. Bioelectron., 2015, 74, 878–885.
2010, 25, 2225–2231. 172 D. Kloß, R. Kurz, H.-G. Jahnke, M. Fischer, A. Rothermel,
147 C. E. Campbell, M. M. Laane, E. Haugarvoll and U. Anderegg, J. C. Simon and A. A. Robitzki, Biosens.
I. Giaever, Biosens. Bioelectron., 2007, 23, 536–542. Bioelectron., 2008, 23, 1473–1480.
148 T. Albrecht, M. Fons, I. Boldogh and A. S. Rabson, Medical 173 S. Fleischer, H.-G. Jahnke, E. Fritsche, M. Girard and
Microbiology, 4th edn, 1996. A. A. Robitzki, Biosens. Bioelectron., 2019, 126, 624–631.
149 M. A. Nahid, C. E. Campbell, K. S. Fong, J. C. Barnhill and 174 M. Eichler, H.-G. Jahnke, D. Krinke, A. Müller, S. Schmidt,
M. A. Washington, J. Microbiol. Methods, 2020, 169, R. Azendorf and A. A. Robitzki, Biosens. Bioelectron., 2015,
105833. 67, 582–589.
150 Y. Fang, P. Ye, X. Wang, X. Xu and W. Reisen, J. Virol. 175 S. E. De León, A. Pupovac and S. L. McArthur, Biotechnol.
Methods, 2011, 173, 251–258. Bioeng., 2020, 117, 1230–1240.
151 M. H. McCoy and E. Wang, J. Virol. Methods, 2005, 130, 176 H. Thielecke, A. Mack and A. Robitzki, Fresenius’ J. Anal.
157–161. Chem., 2001, 369, 23–29.
152 C. J. Thieulent, E. S. Hue, C. I. Fortier, P. Dallemagne, 177 V. Curto, M. Ferro, F. Mariani, E. Scavetta and R. Owens,
S. Zientara, H. Munier-Lehmann, A. Hans, G. D. Fortier, Lab Chip, 2018, 18, 933–943.
P.-H. Pitel and P.-O. Vidalain, Virology, 2019, 526, 105– 178 H.-G. Jahnke, A. Mewes, F. D. Zitzmann, S. Schmidt,
116. R. Azendorf and A. A. Robitzki, Sci. Rep., 2019, 9, 1–10.
153 M. R. Pennington and G. R. Van de Walle, mSphere, 2017, 179 J. A. Stolwijk and J. Wegener, Label-Free Monitoring of Cells
2(2), DOI: 10.1128/msphere.00039-17. In Vitro, 2019, pp. 1–75.
154 J. Piret, N. Goyette and G. Boivin, J. Clin. Microbiol., 2016, 180 M. F. Peters and C. W. Scott, SLAS Discovery, 2009, 14,
54, 2120–2127. 246–255.
155 S. Marlina, M.-H. Shu, S. AbuBakar and K. Zandi, 181 S. Arman, V. R. Gonçales, Y. Yang, R. D. Tilley, K. Gaus
Parasites Vectors, 2015, 8, 1–10. and J. J. Gooding, Electroanalysis, 2023, 35, e202300124.
156 Z. Teng, X. Kuang, J. Wang and X. Zhang, J. Virol. 182 M. Oberleitner and M. Oberleitner, Label-free and Multi-
Methods, 2013, 193, 364–370. parametric Monitoring of Cell-based Assays with Substrate-
157 P. T. Witkowski, L. Schuenadel, J. Wiethaus, embedded Sensors, 2018, pp. 151–293.
D. R. Bourquain, A. Kurth and A. Nitsche, Biochem. 183 S. Michaelis, J. Wegener and R. Robelek, Biosens.
Biophys. Res. Commun., 2010, 401, 37–41. Bioelectron., 2013, 49, 63–70.
158 D. Tian, W. Zhang, J. He, Y. Liu, Z. Song, Z. Zhou, 184 C. Wu, J. Zhou, N. Hu, D. Ha, X. Miao and P. Wang, Sens.
M. Zheng and Y. Hu, PLoS One, 2012, 7, e31965. Actuators, A, 2013, 199, 136–142.
159 C. Charretier, A. Saulnier, L. Benair, C. Armanet, I. Bassard, 185 K. F. Lei, M.-H. Wu, C.-W. Hsu and Y.-D. Chen, Biosens.
S. Daulon, B. Bernigaud, E. R. de Sousa, C. Gonthier and Bioelectron., 2014, 51, 16–21.
E. Zorn, J. Virol. Methods, 2018, 252, 57–64. 186 Y. Zhao, X. Zhao, D. Chen, Y. Luo, M. Jiang, C. Wei,
160 P. Banerjee and A. K. Bhunia, Trends Biotechnol., 2009, 27, R. Long, W. Yue, J. Wang and J. Chen, Biosens.
179–188. Bioelectron., 2014, 57, 245–253.
187 W. Fan, X. Chen, Y. Ge, Y. Jin, Q. Jin and J. Zhao, Biosens. 196 Z. Lin, S.-Y. Lin, P. Xie, C.-Y. Lin, G. M. Rather,
Bioelectron., 2019, 145, 111730. J. R. Bertino and M. Javanmard, Sci. Rep., 2020, 10, 3015.
188 J. Lum, R. Wang, K. Lassiter, B. Srinivasan, D. Abi- 197 S. Zhu, X. Zhang, Z. Zhou, Y. Han, N. Xiang and Z. Ni,
Ghanem, L. Berghman, B. Hargis, S. Tung, H. Lu and Talanta, 2021, 233, 122571.
Y. Li, Biosens. Bioelectron., 2012, 38, 67–73. 198 I. Bilican, M. T. Guler, M. Serhatlioglu, T. Kirindi and
189 S. Kim, H. Song, H. Ahn, T. Kim, J. Jung, S. K. Cho, C. Elbuken, Sens. Actuators, B, 2020, 307, 127531.
D.-M. Shin, J.-r. Choi, Y.-H. Hwang and K. Kim, 199 Y.-S. Chen, C.-H. Huang, P.-C. Pai, J. Seo and K. F. Lei,
Biosensors, 2021, 11, 412. Biosensors, 2023, 13, 83.
190 H. E. Ayliffe, A. B. Frazier and R. Rabbitt, 200 Y. Cho, H. S. Kim, A. B. Frazier, Z. G. Chen, D. M. Shin
J. Microelectromech. Syst., 1999, 8, 50–57. and A. Han, J. Microelectromech. Syst., 2009, 18, 808–817.
191 J. Chen, C. Xue, Y. Zhao, D. Chen, M.-H. Wu and J. Wang, 201 T. A. Nguyen, T.-I. Yin, D. Reyes and G. A. Urban, Anal.
Int. J. Mol. Sci., 2015, 16, 9804–9830. Chem., 2013, 85, 11068–11076.
192 D. Spencer, V. Hollis and H. Morgan, Biomicrofluidics, 202 Y. Feng, L. Huang, P. Zhao, F. Liang and W. Wang, Anal.
2014, 8, 064124. Chem., 2019, 91, 15204–15212.
Published on 23 November 2023. Downloaded on 12/2/2023 4:07:44 AM.
193 C. Dalmay, M. Cheray, A. Pothier, F. Lalloué, M. Jauberteau 203 Y. Zheng, J. Nguyen, Y. Wei and Y. Sun, Lab Chip, 2013,
and P. Blondy, Sens. Actuators, A, 2010, 162, 189–197. 13, 2464–2483.
194 J.-L. Hong, K.-C. Lan and L.-S. Jang, Sens. Actuators, B, 204 A. Adamo, A. Sharei, L. Adamo, B. Lee, S. Mao and
2012, 173, 927–934. K. F. Jensen, Anal. Chem., 2012, 84(15), 6438–6443.
195 N.-V. Nguyen and C.-P. Jen, Biosens. Bioelectron., 2018, 205 P. Ghassemi, X. Ren, B. M. Foster, B. A. Kerr and M. Agah,
121, 10–18. Biosens. Bioelectron., 2020, 150, 111868.